News | November 16, 2025
Kilitch Drugs H! FY26 PAT up 18% YoY to Rs. 10.30 Cr
Total income for the period stood at Rs. 7101.28 crore
Total income for the period stood at Rs. 7101.28 crore
The new formulation features what Abbott calls a “triple care system,” anchored by a blend of nutrients aimed at supporting blood sugar control and metabolic health
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
Leuprolide Acetate injection is indicated in the palliative treatment of advanced prostatic cancer
The observations are procedural in nature and will be responded to within the stipulated time
The investment in land is Rs. 19.85 crore
The trial will evaluate safety endpoints including dose-limiting toxicities and adverse events
LANXESS will highlight its commitment to combatting antimicrobial resistance by presenting science-based disinfection solutions
Diroximel fumarate delayed-release capsules, 231 mg, are indicated for the treatment of relapsing forms of multiple sclerosis
Subscribe To Our Newsletter & Stay Updated
